Navigation Links


Organon at Biology News

Organon at Biology Products
Organon at Biology Technology
Organon at Medicine News

New fertility drug development techniques by Organon

In the 7th International Symposium on GnRH Analogs in Cancer and Human Reproduction, Organon presented new techniques of development of fertility drugs. Organon scientists have succeeded in customizing the follicle-stimulating hormone(FSH) molecule by adding a hybrid subunit, which extends FSH's active life. This was achieved through an international collaboration. This longer active life will me...
Organon at Medicine Products
Organon at Medicine Technology

Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine

OSS, The Netherlands, June 11, 2007 /PRNewswire/ -- Sugammadex -the novel selective relaxant binding agent (SRBA) being developedby Organon, the human healthcare business unit of Akzo Nobel -demonstrated in a Phase III pivotal trial a 9-12 times fasterreversal of neuromuscular blockade as compared to neostigmine,without evidence of post operative residual curarization (PORC) orre-occurre...

Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial Compared to Neostigmine

OSS, the Netherlands, June 11, 2007-Sugammadex - the novelselective relaxant binding agent (SRBA) being developed by Organon,the human healthcare business unit of Akzo Nobel - demonstrated ina Phase III pivotal trial a 9-12 times faster reversal ofneuromuscular blockade as compared to neostigmine, without evidenceof post operative residual curarization (PORC) or re-occurrence ofmuscle relax...

Organon's Asenapine Effective in a Phase III Study for the Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA Meeting

SAN DIEGO, May 21, 2007 /PRNewswire/ -- Asenapine -- aninvestigational drug being developed by Organon, the humanhealthcare business unit of Akzo Nobel, for bipolar I disorder andschizophrenia -- was demonstrated to be more effective than placeboin treating acute manic and mixed episodes associated with bipolarI disorder, according to new Phase III results, from a studypresented at the A...
Other TagsContinenceAcellularAcellularRMSRMSRMSRMSRMSContiContiContiContiContiHDR
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
(Date:8/20/2008)... New Investor Spark Capital Leads Round with Ad...articipation from Existing Investors Including ...hman Brothers., NEW YORK, Aug. 20 /PRNewswire/ --... secured $44.4 million in venture funding. Led by ...es a second investor Syncom Venture,Partners, and ...
(Date:8/20/2008)... , Would you like a lemony watermelon? How about ...niversity of Texas Medical School at Houston say t...to fine tune enzymes responsible for flavors in fr... environmentally-friendly pest control. , In the..., UT Medical School Assistant Professor C.S. Raman...
(Date:8/20/2008)... , , WEST LAFAYETTE, Ind. - Engineers have create...wice the dexterity of similar devices being ,deve...sors and more ,compact, powerful computer hard dr...ve, might be used as a ,"nanoscale manipulator" t...s. The devices also can be used in watery environm...
(Date:8/20/2008)... , HANOVER, NH Embracing the belief that an inte...have a profound impact on advancing science and in... a roadmap for improving our understanding of how ...o the fish we eat. , Members of Dartmouth,s Toxi... leading scientists, environmental regulators, and...
Breaking Biology News(10 mins):Clear(R) Secures $44.4 Million in Venture Funding 2Clear(R) Secures $44.4 Million in Venture Funding 3Biochemists manipulate fruit flavor enzymes 2New 'nano-positioners' may have atomic-scale precision 2New 'nano-positioners' may have atomic-scale precision 3Dartmouth workshop sets research agenda for environmental mercury 2DARA Announces Surgi Vision Agreement with Boston Scientific Corporation 17039 1DARA Announces Surgi Vision Agreement with Boston Scientific Corporation 17039 2DARA Announces Surgi Vision Agreement with Boston Scientific Corporation 17039 3NLRB Orders New Union Election at OConnor Woods 17037 1NLRB Orders New Union Election at OConnor Woods 17037 2Sigma 28R 29 Launches Innovative ChIP Kit Technology For Epigenetic Research 4659 1Sigma 28R 29 Launches Innovative ChIP Kit Technology For Epigenetic Research 4659 2Sigma 28R 29 Launches Innovative ChIP Kit Technology For Epigenetic Research 4659 3Danong Chen appointed CEO of Theranostics Health 4657 1Danong Chen appointed CEO of Theranostics Health 4657 2
Other Contentscardiogeniccardiogeniccardiologycardiologycardiologycardiologycardiologytamponadecardiopulmonarycardiopulmonarycardiopulmonarycardiovascularcardiovascularcardiovascularcardiovascularcardiovascularcardiovascularcardiovascularcardioversionoiloiloiloiloiloiloiloilcastor